Aromatase inhibitors (AIs) are a cornerstone of adjuvant therapy for hormone receptor–positive breast cancer, significantly reducing recurrence and mortality. However, by suppressing estrogen production, AIs accelerate bone loss and increase ...
A coalition of leading international experts in nephrology, bone health, and musculoskeletal disease has released the first comprehensive Consensus Statement on the Management of Vertebral Fractures in Chronic Kidney Disease ...
Accurate laboratory results are essential for clinical decisions — but every measurement carries some uncertainty.
Addressing this challenge, the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)–International Osteoporosis Foundation ...
The International Osteoporosis Foundation (IOF) has issued a landmark Position Paper identifying critical global barriers to osteoporosis care and calling for urgent change to improve access to effective fracture prevention ...
A new review by the International Osteoporosis Foundation (IOF) Rehabilitation Working Group underscores the powerful impact of lifestyle behaviours—specifically physical activity and sedentary behaviour —on bone health across the human ...
An updated joint position statement on the management of aromatase inhibitor-associated bone loss (AIBL) addresses the heightened fracture risk in women undergoing endocrine therapy for estrogen-responsive breast cancer, providing practical ...
The International Osteoporosis Foundation (IOF) Bone and Cancer Working Group has released a comprehensive review detailing the often underrecognized impact of modern anti-cancer treatments on bone health. Published in ...
A landmark narrative review published by the Bone and Diabetes Working Group of the International Osteoporosis Foundation (IOF) Committee of Scientific Advisors reveals critical insights into how diabetes mellitus alters ...
IOF invites to its BoneCast webinar of July 3, 2025, focused on the role of bone turnover markers in osteoporosis diagnosis and management.
Bone turnover markers (BTMs) have become essential ...
A new consensus paper, published by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), the International Osteoporosis Foundation (IOF), and the International Federation ...
Although osteoporosis and related fractures impose a significant and growing burden, the management of this disease, even following fractures, is on the decline. A new groundbreaking pilot study carried out ...
The Joint International Osteoporosis Foundation (IOF) Working Group and the International Federation of Clinical Chemistry (IFCC) Committee on Bone Metabolism have published important updated guidelines for the correct use of ...